» Articles » PMID: 23353640

External Validation of the Fatty Liver Index for Identifying Nonalcoholic Fatty Liver Disease in a Population-based Study

Overview
Specialty Gastroenterology
Date 2013 Jan 29
PMID 23353640
Citations 129
Authors
Affiliations
Soon will be listed here.
Abstract

Background & Aims: We aimed to validate the fatty liver index (FLI), an algorithm that is based on waist circumference, body mass index, and levels of triglyceride and γ-glutamyltransferase. We calculated its ability to identify fatty liver disease from any cause or nonalcoholic fatty liver disease (NAFLD) in a large population of white elderly persons.

Methods: We collected ultrasonography and FLI data from participants of the Rotterdam Study from February 2009 to February 2012; 2652 subjects (mean age, 76.3 ± 6.0 years) were interviewed and received a clinical examination that included abdominal ultrasound, analysis of blood samples during fasting, and anthropometric assessment. The ability of the FLI to detect (nonalcoholic) fatty liver was assessed by using area under the receiver operator characteristic (AUROC) curve analysis.

Results: FLI score was associated with NAFLD in multivariable analysis (odds ratio, 1.05; 95% confidence interval [CI], 1.04-1.05; P < .001). FLI identified patients with NAFLD with an AUROC curve of 0.813 (95% CI, 0.797-0.830) and those with fatty liver from any cause with an AUROC curve of 0.807 (95% CI, 0.792-0.823).

Conclusions: The FLI (an algorithm that is based on waist circumference, body mass index, and levels of triglyceride and γ-glutamyltransferase) accurately identifies NAFLD, confirmed via ultrasonography, in a large, white, elderly population.

Citing Articles

Metabolic dysfunction associated steatotic liver disease is associated with atrial fibrillation recurrence following cryoballoon ablation.

Wang Y, Chen Z, Wei B, Zhang R, Zhang X, Xu W Sci Rep. 2025; 15(1):6287.

PMID: 39984596 PMC: 11845672. DOI: 10.1038/s41598-025-90667-z.


Impact of steatotic liver disease subtypes, sarcopenia, and fibrosis on all-cause and cause-specific mortality: a 15.7-year cohort study.

Liang Y, Ye X, Pan M, Chen Y, Yuan Y, Luo L BMC Gastroenterol. 2025; 25(1):75.

PMID: 39934679 PMC: 11818238. DOI: 10.1186/s12876-025-03661-0.


Association of dietary quality and mortality in the non-alcoholic fatty liver disease and advanced fibrosis populations: NHANES 2005-2018.

Huang X, Zhang X, Hao X, Wang T, Wu P, Shen L Front Nutr. 2025; 12:1507342.

PMID: 39917744 PMC: 11798782. DOI: 10.3389/fnut.2025.1507342.


Nonalcoholic Fatty Liver Disease Increases the Risk of Lung Abscess: Findings from a Nationwide Cohort Study.

Lee E, Kim J, Yoon S J Clin Med. 2025; 14(2).

PMID: 39860549 PMC: 11765748. DOI: 10.3390/jcm14020542.


Determining the sensitivity and specificity of the calculated fatty liver index in comparison with ultrasound.

Saberian A, Dehghan A, Homayounfar R, Kaffashan S, Zarei F, Niknejad S BMC Gastroenterol. 2024; 24(1):443.

PMID: 39623301 PMC: 11610269. DOI: 10.1186/s12876-024-03535-x.